A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
Clinical trial NCT06008015 · COMPLETED
Trial details
- NCT number
- NCT06008015
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-04
- Primary completion
- 2023-10-03
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.